Search Results - "Nomura, Hiroyuki"

Refine Results
  1. 1
  2. 2
  3. 3

    A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan by Mitani, Takeji, Kukimoto, Iwao, Tsukamoto, Tetsuya, Nomura, Hiroyuki, Fujii, Takuma

    Published in Scientific reports (01-02-2024)
    “…Approximately 500,000 women are diagnosed with cervical cancer annually, with high-grade cervical intraepithelial neoplasia (CIN) estimated to be 20 times…”
    Get full text
    Journal Article
  4. 4

    Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial by Tamura, Kenji, Hasegawa, Kosei, Katsumata, Noriyuki, Matsumoto, Koji, Mukai, Hirofumi, Takahashi, Shunji, Nomura, Hiroyuki, Minami, Hironobu

    Published in Cancer science (01-09-2019)
    “…Nivolumab is a human monoclonal antibody against the immune checkpoint receptor programmed death‐1, inhibiting binding to programmed death‐ligand 1 or 2 (PD‐L1…”
    Get full text
    Journal Article
  5. 5

    A Possible Inhibitory Role of Sialic Acid on MUC1 in Peritoneal Dissemination of Clear Cell-Type Ovarian Cancer Cells by Tamada, Yutaka, Nomura, Hiroyuki, Aoki, Daisuke, Irimura, Tatsuro

    Published in Molecules (Basel, Switzerland) (01-10-2021)
    “…The role of sialic acids on MUC1 in peritoneal dissemination of ovarian cancer cells was investigated. A human ovarian carcinoma cell line, ES-2, was…”
    Get full text
    Journal Article
  6. 6

    Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia by Kawahara, Rina, Fujii, Takuma, Kukimoto, Iwao, Nomura, Hiroyuki, Kawasaki, Rie, Nishio, Eiji, Ichikawa, Ryoko, Tsukamoto, Tetsuya, Iwata, Aya

    Published in Scientific reports (25-01-2021)
    “…Persistent HPV infection associated with immune modulation may result in high-grade squamous intraepithelial lesions (CIN)2/3. Currently, there is little…”
    Get full text
    Journal Article
  7. 7

    Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan by Miki, Michiyasu, Imaeda, Yoshihiro, Takahashi, Hiroshi, Iwata, Aya, Tsukamoto, Tetsuya, Nomura, Hiroyuki, Kotani, Kiriko, Mitani, Takeji, Ichikawa, Ryoko, Fujii, Takuma

    Published in International journal of clinical oncology (01-02-2022)
    “…Background As the population ages in developed countries, the number of Pap smears for cervical cancer screening of older women is increasing. There is concern…”
    Get full text
    Journal Article
  8. 8

    Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan by Sekine, Masayuki, Enomoto, Takayuki, Arai, Masami, Yokoyama, Shiro, Nomura, Hiroyuki, Nishino, Koji, Ikeuchi, Takeshi, Kuriyama, Yoko, Nakamura, Seigo

    Published in Journal of human genetics (01-05-2022)
    “…We previously reported that L63X and Q934X are BRCA1 common founder variants in Japan. So far, there have been no reports of a correlation between such BRCA…”
    Get full text
    Journal Article
  9. 9

    Nomogram for predicted probability of cervical cancer and its precursor lesions using miRNA in cervical mucus, HPV genotype and age by Kotani, Kiriko, Iwata, Aya, Kukimoto, Iwao, Nishio, Eiji, Mitani, Takeji, Tsukamoto, Tetsuya, Ichikawa, Ryoko, Nomura, Hiroyuki, Fujii, Takuma

    Published in Scientific reports (28-09-2022)
    “…Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer by Takahashi, Shunji, Takekuma, Munetaka, Tamura, Kenji, Takehara, Kazuhiro, Nomura, Hiroyuki, Ono, Makiko, Yunokawa, Mayu, Aoki, Daisuke

    Published in International journal of clinical oncology (01-10-2021)
    “…Background Advanced relapsed ovarian cancer has a poor prognosis, and treatment options are limited. Methods This phase I trial investigated the dosage,…”
    Get full text
    Journal Article
  12. 12

    Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy by Sekine, Masayuki, Enomoto, Takayuki, Arai, Masami, Den, Hiroki, Nomura, Hiroyuki, Ikeuchi, Takeshi, Nakamura, Seigo

    Published in Journal of gynecologic oncology (01-07-2022)
    “…and mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) by age 40 and 45, respectively. However, the carriers have a…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    Parametric standing wave generation of a shallow reflection plane in a nonrigid sample for use in a noninvasive blood glucose monitor by Kitazaki, Tomoya, Kawashima, Natsumi, Yamamoto, Naoyuki, Nomura, Hiroyuki, Kang, Hanyue, Nishiyama, Akira, Wada, Kenji, Ishimaru, Ichiro

    Published in Journal of biomedical optics (01-03-2019)
    “…When monitoring a moist sample using mid-infrared spectroscopy, its thickness must be <100  μm to avoid light absorption from the water. Therefore, we propose…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Application of MicroRNA in Diagnosis and Treatment of Ovarian Cancer by Masuda, Kenta, Kisu, Iori, Nomura, Hiroyuki, Kataoka, Fumio, Tominaga, Eiichiro, Aoki, Daisuke, Banno, Kouji, Umene, Kiyoko, Nogami, Yuya, Nakamura, Kanako, Yanokura, Megumi, Iida, Miho, Adachi, Masataka

    Published in BioMed research international (01-01-2014)
    “…Ovarian cancer has a poor prognosis because early detection is difficult and recurrent ovarian cancer is usually drug-resistant. The morbidity and mortality of…”
    Get full text
    Journal Article
  20. 20